Department of Physiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of General Pediatrics, University Children's Hospital, Münster, Germany.
J Am Soc Nephrol. 2022 Feb;33(2):305-325. doi: 10.1681/ASN.2021050596. Epub 2021 Oct 4.
Gitelman syndrome is the most frequent hereditary salt-losing tubulopathy characterized by hypokalemic alkalosis and hypomagnesemia. Gitelman syndrome is caused by biallelic pathogenic variants in encoding the Na-Cl cotransporter (NCC) expressed in the distal convoluted tubule. Pathogenic variants of , , , or may result in the same renal phenotype of Gitelman syndrome, as they can lead to reduced NCC activity. For approximately 10 percent of patients with a Gitelman syndrome phenotype, the genotype is unknown.
We identified mitochondrial DNA (mtDNA) variants in three families with Gitelman-like electrolyte abnormalities, then investigated 156 families for variants in and , which encode the transfer RNAs for phenylalanine and isoleucine. Mitochondrial respiratory chain function was assessed in patient fibroblasts. Mitochondrial dysfunction was induced in NCC-expressing HEK293 cells to assess the effect on thiazide-sensitive Na transport.
Genetic investigations revealed four mtDNA variants in 13 families: m.591C>T (=7), m.616T>C (=1), m.643A>G (=1) (all in ), and m.4291T>C (=4, in ). Variants were near homoplasmic in affected individuals. All variants were classified as pathogenic, except for m.643A>G, which was classified as a variant of uncertain significance. Importantly, affected members of six families with an variant additionally suffered from progressive chronic kidney disease. Dysfunction of oxidative phosphorylation complex IV and reduced maximal mitochondrial respiratory capacity were found in patient fibroblasts. pharmacological inhibition of complex IV, mimicking the effect of the mtDNA variants, inhibited NCC phosphorylation and NCC-mediated sodium uptake.
Pathogenic mtDNA variants in and can cause a Gitelman-like syndrome. Genetic investigation of mtDNA should be considered in patients with unexplained Gitelman syndrome-like tubulopathies.
Gitelman 综合征是最常见的遗传性失盐性肾小管疾病,其特征为低钾性碱中毒和低镁血症。Gitelman 综合征是由编码在远曲小管表达的 Na-Cl 共转运蛋白(NCC)的 双等位基因致病性变异引起的。 、 、 或 的致病性变异可导致 Gitelman 综合征的相同肾表型,因为它们可导致 NCC 活性降低。大约 10%具有 Gitelman 综合征表型的患者,其基因型未知。
我们在三个具有 Gitelman 样电解质异常的家系中鉴定了线粒体 DNA(mtDNA)变异,然后调查了 156 个家系中编码苯丙氨酸和异亮氨酸转移 RNA 的 和 中的变异。评估了患者成纤维细胞中线粒体呼吸链功能。在表达 NCC 的 HEK293 细胞中诱导线粒体功能障碍,以评估其对噻嗪类敏感的 Na 转运的影响。
遗传研究揭示了 13 个家系中的 4 种 mtDNA 变异:m.591C>T(=7)、m.616T>C(=1)、m.643A>G(=1)(均在 )和 m.4291T>C(=4,在 )。受影响个体中的变异均为近同质合子。除 m.643A>G 外,所有变异均被归类为致病性变异,m.643A>G 被归类为意义不明的变异。重要的是,6 个具有 变异的家系中受影响的成员还患有进行性慢性肾脏病。在患者成纤维细胞中发现氧化磷酸化复合物 IV 功能障碍和最大线粒体呼吸能力降低。NCC 磷酸化和 NCC 介导的钠摄取被 药理学抑制复合物 IV 模拟这些 mtDNA 变异的作用而抑制。
和 中的致病性 mtDNA 变异可引起 Gitelman 样综合征。对于原因不明的 Gitelman 样肾小管疾病患者,应考虑进行 mtDNA 遗传调查。